Matches in Wikidata for { <http://www.wikidata.org/entity/Q37720016> ?p ?o ?g. }
- Q37720016 description "article científic" @default.
- Q37720016 description "article scientifique" @default.
- Q37720016 description "articolo scientifico" @default.
- Q37720016 description "artigo científico" @default.
- Q37720016 description "artículu científicu espublizáu en 2017" @default.
- Q37720016 description "bilimsel makale" @default.
- Q37720016 description "scientific article published on 13 January 2017" @default.
- Q37720016 description "vedecký článok" @default.
- Q37720016 description "vetenskaplig artikel" @default.
- Q37720016 description "videnskabelig artikel" @default.
- Q37720016 description "vědecký článek" @default.
- Q37720016 description "wetenschappelijk artikel" @default.
- Q37720016 description "wissenschaftlicher Artikel" @default.
- Q37720016 description "наукова стаття, опублікована в січні 2017" @default.
- Q37720016 description "научни чланак" @default.
- Q37720016 description "مقالة علمية نشرت في 13 يناير 2017" @default.
- Q37720016 name "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells." @default.
- Q37720016 name "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells." @default.
- Q37720016 name "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells." @default.
- Q37720016 type Item @default.
- Q37720016 label "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells." @default.
- Q37720016 label "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells." @default.
- Q37720016 label "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells." @default.
- Q37720016 prefLabel "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells." @default.
- Q37720016 prefLabel "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells." @default.
- Q37720016 prefLabel "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells." @default.
- Q37720016 P1433 Q37720016-45A7E1E0-94BD-4209-86C1-70487A89DBEC @default.
- Q37720016 P1476 Q37720016-4FA67C45-E353-4AF0-91B8-26358949FC99 @default.
- Q37720016 P2093 Q37720016-12C2021E-E2B4-41CB-A9A2-E22E35B414E5 @default.
- Q37720016 P2093 Q37720016-4F755346-6A5F-4AE8-8A68-163BF9CA716D @default.
- Q37720016 P2093 Q37720016-C438F0C9-88C7-4081-9310-748894173A52 @default.
- Q37720016 P2860 Q37720016-008B685D-718A-42B6-953E-417149DA7E09 @default.
- Q37720016 P2860 Q37720016-0093A57F-772D-4725-A259-E865E416BF30 @default.
- Q37720016 P2860 Q37720016-00A8C286-A587-459A-B195-D2FEB2D74FD2 @default.
- Q37720016 P2860 Q37720016-02D85759-DEE5-4247-AE0D-BF5549F66185 @default.
- Q37720016 P2860 Q37720016-053A4D33-4625-4D46-9A97-CDEF34A8D823 @default.
- Q37720016 P2860 Q37720016-070511C6-9E03-4BAD-A932-711FCB4AC86C @default.
- Q37720016 P2860 Q37720016-1724550F-5834-46DA-A018-F47FBC2FA710 @default.
- Q37720016 P2860 Q37720016-188466D3-9ABA-47EE-B03F-50E4CAF72909 @default.
- Q37720016 P2860 Q37720016-1C351AC1-2509-4644-B847-2A9744A4D576 @default.
- Q37720016 P2860 Q37720016-1E864F15-0E84-4EB7-9EF2-A71C463160BF @default.
- Q37720016 P2860 Q37720016-275D8465-D9DE-4BE7-8298-1A6AA1959192 @default.
- Q37720016 P2860 Q37720016-29595F18-01EA-4EF4-ACC2-4D8A685C895A @default.
- Q37720016 P2860 Q37720016-2FAA486F-1A6C-43D8-9089-CD874BEE2DCD @default.
- Q37720016 P2860 Q37720016-3C1D9BDB-DE26-462D-95BF-DC9390F7990F @default.
- Q37720016 P2860 Q37720016-3C54742A-388A-47FF-A0EB-B31C3709A176 @default.
- Q37720016 P2860 Q37720016-43CC0CEF-675B-4C88-AA4C-EC8BADE278C4 @default.
- Q37720016 P2860 Q37720016-4B130F4F-614A-41ED-A157-29695993DD13 @default.
- Q37720016 P2860 Q37720016-4DB6FD59-2713-4B32-A635-94733A1E169D @default.
- Q37720016 P2860 Q37720016-4EBF1669-7427-4D14-B03F-B30519CF6F05 @default.
- Q37720016 P2860 Q37720016-55476283-1EBA-4B90-9E97-A0F6376AE447 @default.
- Q37720016 P2860 Q37720016-794A7CAD-D294-4043-949D-FBB892B7C2C2 @default.
- Q37720016 P2860 Q37720016-81285E1D-770E-4097-B265-FCAF4A465784 @default.
- Q37720016 P2860 Q37720016-8424DBC2-D750-42C2-8338-860D76FAAF98 @default.
- Q37720016 P2860 Q37720016-847B20F6-4109-46E8-8DB3-64FE233CB72F @default.
- Q37720016 P2860 Q37720016-873F40E5-EB38-4AED-90A0-32DC70F854B6 @default.
- Q37720016 P2860 Q37720016-8F2BC5DA-2C8E-4ABA-9E0E-7CCAC470C8FB @default.
- Q37720016 P2860 Q37720016-91E0DCDC-8125-4C8C-A073-DB9581313590 @default.
- Q37720016 P2860 Q37720016-9874CC23-8F39-491B-ABBD-AA9AD3738AE5 @default.
- Q37720016 P2860 Q37720016-9947BF78-EB15-4885-BE83-4306875A34B4 @default.
- Q37720016 P2860 Q37720016-9987C502-2335-4FCD-A548-9017FCB8E327 @default.
- Q37720016 P2860 Q37720016-9B7C41B3-4A73-45E2-ADAF-BAFD575A00AD @default.
- Q37720016 P2860 Q37720016-A0C798ED-EA7B-44E1-8791-63AC82BE17A9 @default.
- Q37720016 P2860 Q37720016-A4533492-E09F-4553-93D7-05D802EE39E4 @default.
- Q37720016 P2860 Q37720016-AB955F9F-55F8-40E8-A43C-26B1693F1BC0 @default.
- Q37720016 P2860 Q37720016-ACB66FD2-41B4-429C-93D6-DFB0A9054D04 @default.
- Q37720016 P2860 Q37720016-B065FAE1-49F3-46A6-B444-9BFB1ADF513B @default.
- Q37720016 P2860 Q37720016-BDE35771-5877-45B7-A082-C0D532C77DAC @default.
- Q37720016 P2860 Q37720016-C3358618-BB8E-4E2A-9407-6E30ED66D3FC @default.
- Q37720016 P2860 Q37720016-C9E4C588-C522-44CA-9DEC-C660568E05BF @default.
- Q37720016 P2860 Q37720016-CE94D251-7714-4A58-AFE1-B8C6F0BE33E6 @default.
- Q37720016 P2860 Q37720016-D9487D39-B139-46F9-89A8-9011B384CDBD @default.
- Q37720016 P2860 Q37720016-DC66F434-224C-4FC5-AA47-D5398432D7CE @default.
- Q37720016 P2860 Q37720016-E3E37D97-2281-42F0-9963-BD471B37CA47 @default.
- Q37720016 P2860 Q37720016-E4081F20-8B82-4F2D-8D30-D393DA3BDB4B @default.
- Q37720016 P2860 Q37720016-E73BA6FE-5138-4AA8-872A-75C4DDD6E65B @default.
- Q37720016 P2860 Q37720016-EFEC9189-8159-4A35-8F95-99F5D1A2A917 @default.
- Q37720016 P2860 Q37720016-F0ACF0E4-A428-4C4E-9C2A-16390B537C9E @default.
- Q37720016 P2860 Q37720016-F4E62233-A717-4C2D-AC9D-84E5E6B0D8ED @default.
- Q37720016 P2860 Q37720016-F4F15A7A-D932-41E5-AA90-09256FB6BCDF @default.
- Q37720016 P2860 Q37720016-FD7858C3-90D2-45D6-95FA-FD5168AB6EF5 @default.
- Q37720016 P304 Q37720016-2D44610D-7EB1-4BE5-9551-8F62896E30FE @default.
- Q37720016 P31 Q37720016-B3FAB420-7253-483D-8A80-C5EADF406441 @default.
- Q37720016 P356 Q37720016-8BBC7940-AB81-40B9-A3EF-EF35B11D0E32 @default.
- Q37720016 P433 Q37720016-C7F0B798-7964-4CCA-A972-04B0A2584347 @default.
- Q37720016 P4510 Q37720016-777D6E1B-FCFF-4771-B9DD-EAECF3CE27AA @default.
- Q37720016 P478 Q37720016-DAECA314-6D5B-4F70-B47C-024A43807867 @default.
- Q37720016 P50 Q37720016-F643C6CD-D57D-4F40-8379-D5AF23940FA9 @default.
- Q37720016 P577 Q37720016-ECF3DF67-5A97-40EB-B034-E29C4AB43DC9 @default.
- Q37720016 P698 Q37720016-4AE82B25-061B-4C5C-9F22-615396CD0508 @default.
- Q37720016 P8608 Q37720016-E4E5F84F-347A-4291-98B8-1D340672A1A6 @default.
- Q37720016 P932 Q37720016-440C3BA8-919F-4583-9768-D226FBA0A6DF @default.
- Q37720016 P356 OR.2017.5363 @default.
- Q37720016 P698 28098866 @default.
- Q37720016 P1433 Q7092098 @default.
- Q37720016 P1476 "In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells" @default.
- Q37720016 P2093 "Antonela Barón" @default.
- Q37720016 P2093 "Erika María von Euw" @default.
- Q37720016 P2093 "José Mordoh" @default.
- Q37720016 P2860 Q21004109 @default.